84年鼠女哪年财运最旺,857comvvv色九欧美激情|85PO_87国产精品欲av国产av资源

[1]陳敏,余澤蕓,宋丹,等.老年膝骨關(guān)節(jié)炎合并肌少癥的影響因素分析及風(fēng)險預(yù)測模型構(gòu)建[J].中醫(yī)正骨,2025,37(03):23-28,38.
 CHEN Min,YU Zeyun,SONG Dan,et al.Influencing factors and a risk forecasting model for knee osteoarthritis complicated with sarcopenia in the aged[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2025,37(03):23-28,38.
點擊復(fù)制

老年膝骨關(guān)節(jié)炎合并肌少癥的影響因素分析及風(fēng)險預(yù)測模型構(gòu)建()
分享到:

《中醫(yī)正骨》[ISSN:1001-6015/CN:41-1162/R]

卷:
第37卷
期數(shù):
2025年03期
頁碼:
23-28,38
欄目:
臨床研究
出版日期:
2025-03-20

文章信息/Info

Title:
Influencing factors and a risk forecasting model for knee osteoarthritis complicated with sarcopenia in the aged
作者:
陳敏余澤蕓宋丹周禮熊小琴
宜賓市第一人民醫(yī)院,四川 宜賓 644000
Author(s):
CHEN MinYU ZeyunSONG DanZHOU LiXIONG Xiaoqin
The First People's Hospital of Yibin,Yibin 644000,Sichuan,China
關(guān)鍵詞:
骨關(guān)節(jié)炎 肌肉衰減征 老年人 Logistic模型 因素分析統(tǒng)計學(xué) 列線圖表 風(fēng)險 預(yù)測
Keywords:
osteoarthritisknee sarcopenia aged logistic models factor analysisstatistical nomograms risk forecasting
摘要:
目的:探討老年膝骨關(guān)節(jié)炎(knee osteoarthritis,KOA)合并肌少癥的影響因素,并構(gòu)建老年KOA合并肌少癥的風(fēng)險預(yù)測模型。方法:選取2020年6月至2024年12月在宜賓市第一人民醫(yī)院住院治療的KOA患者為研究對象。將2020年6月至2024年6月納入的患者歸入模型組(用于模型建立),將2024年7—12月納入的患者歸入為驗證組(用于模型驗證)。采用亞洲肌少癥工作組制定的肌少癥診斷方法診斷肌少癥,收集患者性別、年齡、體質(zhì)量指數(shù)、KOA病程、Kellgren-Lawrence分級、蛋白質(zhì)攝入量、膝關(guān)節(jié)疼痛視覺模擬量表(visual analogue scale,VAS)評分、西安大略和麥克馬斯特大學(xué)骨關(guān)節(jié)炎指數(shù)(Western Ontario and McMaster Universities osteoarthritis index,WOMAC)分級、吸煙、酗酒、規(guī)范治療、規(guī)律運動、合并基礎(chǔ)疾病、鈣劑補充、維生素D補充等信息。將模型組患者根據(jù)是否合并肌少癥,分為合并肌少癥組和不合并肌少癥組。先對合并肌少癥組和不合并肌少癥組患者的相關(guān)信息進行單因素對比分析,對其中組間差異有統(tǒng)計學(xué)意義的因素進行Lasso回歸分析,將Lasso回歸分析篩選出來的因素用于多因素Logistic回歸分析。采用R語言和rms程序包構(gòu)建老年KOA合并肌少癥的列線圖預(yù)測模型。分別基于模型組和驗證組數(shù)據(jù),采用受試者操作特征(receiver operating characteristic,ROC)曲線和Hosmer-Lemeshow擬合優(yōu)度檢驗分別評價老年KOA合并肌少癥列線圖預(yù)測模型的區(qū)分度和校準度。結(jié)果:共納入模型組患者675例,其中合并肌少癥組196例,不合并肌少癥組479例; 納入驗證組患者77例。合并肌少癥組和不合并肌少癥組患者年齡、KOA病程、Kellgren-Lawrence分級、蛋白質(zhì)攝入量、膝關(guān)節(jié)疼痛VAS評分、WOMAC分級、酗酒、規(guī)范治療、規(guī)律運動、合并基礎(chǔ)疾病、維生素D補充情況比較,組間差異均有統(tǒng)計學(xué)意義[(73.8±5.2)歲,(68.3±4.6)歲,t=12.921,P=0.000;(26.5±3.9)個月,(19.6±4.6)個月,t=19.768,P=0.000; χ2=16.171,P=0.000;(59.3±6.5)g·d-1,(63.9±6.3)g·d-1,t=8.475,P=0.000;(5.6±1.7)分,(4.7±1.3)分,t=7.109,P=0.000; χ2=8.627,P=0.013; χ2=8.082,P=0.004; χ2=4.076,P=0.043; χ2=10.096,P=0.001; χ2=10.822,P=0.004; χ2=7.644,P=0.006]。Lasso回歸分析篩選出年齡、KOA病程、Kellgren-Lawrence分級、蛋白質(zhì)攝入量、膝關(guān)節(jié)疼痛VAS評分、規(guī)律運動和 WOMAC 分級為老年KOA合并肌少癥的預(yù)測變量。Logistic回歸分析結(jié)果顯示,年齡、KOA病程和膝關(guān)節(jié)疼痛VAS評分是老年KOA合并肌少癥的危險因素,蛋白質(zhì)攝入量是老年KOA合并肌少癥的保護因素。采用模型組數(shù)據(jù)進行老年KOA合并肌少癥列線圖預(yù)測模型驗證,ROC曲線下面積為0.865[P=0.000,95%CI(0.837,0.892)],采用驗證組數(shù)據(jù)進行老年KOA合并肌少癥列線圖預(yù)測模型驗證,ROC曲線下面積為0.762[P=0.000,95%CI(0.709,0.811)]; Hosmer-Lemeshow擬合優(yōu)度檢驗結(jié)果顯示,模型組最大、最小偏移量分別為0.037、0.011(P=0.885),驗證組最大、最小偏移量分別為0.058、0.031(P=0.773)。結(jié)論:年齡、KOA病程和膝關(guān)節(jié)疼痛VAS評分是老年KOA合并肌少癥的危險因素,蛋白質(zhì)攝入量是老年KOA合并肌少癥的保護因素,基于上述因素構(gòu)建的老年KOA合并肌少癥列線圖預(yù)測模型具有較高的應(yīng)用價值。
Abstract:
Objective:To explore the influencing factors of knee osteoarthritis complicated with sarcopenia in the aged,and to construct a risk prediction model for KOA complicated with sarcopenia in the aged.Methods:The KOA patients hospitalized at The First People's Hospital of Yibin from June 2020 to December 2024 were selected as the subjects.The ones admitted from June 2020 to June 2024 were assigned into the model group(for model building),while those from July 2024 to December 2024 into the validation group(for model validation).The information of the patients,including gender,age,body mass index(BMI),KOA duration,Kellgren-Lawrence(K-L)grade,protein intake,knee pain visual analogue scale(VAS)score,Western Ontario and McMaster Universities osteoarthritis index(WOMAC)grade,smoking,alcohol abuse,standardized treatment,regular exercise,combined with underlying diseases,calcium supplementation,and vitamin D supplementation,was collected,and the sarcopenia was diagnosed among the included KOA patients using the diagnostic methods developed by the Asian Working Group for Sarcopenia(AWGS).According to the results,the KOA patients with and without sarcopenia in model group were subgrouped into a sarcopenia group and a non-sarcopenia group.After that,a single-factor analysis was conducted on the extracted information of patients in the 2 subgroups,followed by a Lasso regression analysis on the factors with statistically significant differences between the 2 subgroups,based on which a multi-factor logistic regression analysis on the factors screened by Lasso regression analysis was performed.According to the findings,a nomogram prediction model for KOA complicated with sarcopenia in the aged was constructed using the R language and rms package,and the discrimination and calibration performance of the nomogram prediction model were analyzed and evaluated by using the receiver operating characteristic(ROC)curve and Hosmer-Lemeshow goodness-of-fit(GOF)test based on the data of model group and validation group,respectively.Results:Seventy-seven patients were enrolled in the validation group,and 675 ones in model group,among which 196 ones in sarcopenia group,and 479 ones in non-sarcopenia group.The single-factor analysis showed significant differences between sarcopenia group and non-sarcopenia group in the age,KOA duration,K-L grade,protein intake,knee pain VAS score,WOMAC grade,alcohol abuse,standardized treatment,regular exercise,combined with underlying diseases,and vitamin D supplementation(73.8±5.2 vs 68.3±4.6 years,t=12.921,P=0.000; 26.5±3.9 vs 19.6±4.6 months,t=19.768,P=0.000; χ2=16.171,P=0.000; 59.3±6.5 vs 63.9±6.3 g/day,t=8.475,P=0.000; 5.6±1.7 vs 4.7±1.3 points,t=7.109,P=0.000; χ2=8.627,P=0.013; χ2=8.082,P=0.004; χ2=4.076,P=0.043; χ2=10.096,P=0.001; χ2=10.822,P=0.004; χ2=7.644,P=0.006).After Lasso regression analysis,age,KOA duration,K-L grade,protein intake,knee pain VAS score,regular exercise,and WOMAC grade were identified as the variables for predicting sarcopenia in the aged KOA patients.The multi-factor logistic regression analysis showed that the age,KOA duration,and knee pain VAS score were the risk factors,while the protein intake was a protective factor for KOA complicated with sarcopenia in the aged.The area under the ROC curve of the nomogram prediction model for KOA complicated with sarcopenia in the aged validated based on the data of model group and validation group was 0.865(P=0.000,95%CI(0.837,0.892))and 0.762(P=0.000,95%CI(0.709,0.811)),respectively.The Hosmer-Lemeshow GOF test showed that the maximum and minimum offsets was 0.037 and 0.011(P=0.885),respectively,in model group,and 0.058 and 0.031(P=0.773),respectively,in validation group.Conclusion:Age,KOA duration,and knee pain VAS score are the risk factors for KOA complicated with sarcopenia,while the protein intake is a protective factor against sarcopenia in the aged KOA patients.The nomogram prediction model constructed based on the above factors has a high clinical applied value in predicting the risk for sarcopenia in the aged KOA patients.

參考文獻/References:

[1] CHEN S,HAN H W,JIN J,et al.Osteoarthritis and sarcopenia-related traits:the cross-sectional study from NHANES 2011-2014 and Mendelian randomization study[J].J Orthop Surg Res,2023,18(1):502.
[2] WU X,LI X,XU M H,et al.Sarcopenia prevalence and associated factors among older Chinese population:findings from the China health and retirement longitudinal study[J].PLoS One,2021,16(3):e0247617.
[3] LONG H B,LIU Q,YIN H Y,et al.Prevalence trends of site-specific osteoarthritis from 1990 to 2019:findings from the global burden of disease study 2019[J].Arthritis Rheumatol,2022,74(7):1172-1183.
[4] YANG J Y,LIU P,WANG S,et al.Causal relationship between sarcopenia and osteoarthritis:a bi-directional two-sample mendelian randomized study[J].Eur J Med Res,2023,28(1):327.
[5] 馬超猛,倪晶,童培建.膝骨關(guān)節(jié)炎與肌少癥的關(guān)系及膝骨關(guān)節(jié)炎合并肌少癥治療方法的研究進展[J].中醫(yī)正骨,2023,35(7):57-63.
[6] CHEN L K,WOO J,ASSANTACHAI P,et al.Asian Working Group for Sarcopenia:2019 consensus update on sarcopenia diagnosis and treatment[J].J Am Med Dir Assoc,2020,21(3):300-307.
[7] SUZUKI Y,IIJIMA H,TASHIRO Y,et al.Home exercise therapy to improve muscle strength and joint flexibility effectively treats pre-radiographic knee OA in community-dwelling elderly:a randomized controlled trial[J].Clin Rheumatol,2019,38(1):133-141.
[8] CUI Q,XIA Y,WU Q J,et al.Validity of the food frequency questionnaire for adults in nutritional epidemiological stu-dies:a systematic review and meta-analysis[J].Crit Rev Food Sci Nutr,2023,63(12):1670-1688.
[9] RIDDLE D L.Development of a score map to guide interpretation of WOMAC pain scores prior to knee arthroplasty[J].Knee,2022,39:153-160.
[10] 中國營養(yǎng)學(xué)會.中國居民膳食指南 2016[M].北京:人民衛(wèi)生出版社,2016:11.
[11] JAUFFRET C,PERICHON R,LAMER A,et al.Association between sarcopenia and fracture risk in a population from the UK Biobank Database[J].J Bone Miner Res,2023,38(10):1422-1434.
[12] REN X Y,ZHANG X L,HE Q,et al.Prevalence of sarcopenia in Chinese community-dwelling elderly:a systematic review[J].BMC Public Health,2022,22(1):1702.
[13] SINATTI P,SANCHEZ R E A,MARTINEZ-POZAS O,et al.Effects of patient education on pain and function and its impact on conservative treatment in elderly patients with pain related to hip and knee osteoarthritis:a systematic review[J].Int J Environ Res Public Healt,2022,19(10):6194.
[14] BENDRIK R,KALLINGS L V,BROMS K,et al.Follow-up of individualised physical activity on prescription and individualised advice in patients with hip or knee osteoarthritis:a randomised controlled trial[J].Clin Rehabil,2024,38(6):770-782.
[15] JIA X M,DENG T T,SU H,et al.Genetic causality and site-specific relationship between sarcopenia and osteoarthritis:a bidirectional Mendelian randomization study[J].Front Genet,2024,14:1340245.
[16] PAPALIA R,ZAMPOGNA B,TORRE G,et al.Sarcopenia and its relationship with osteoarthritis:risk factor or direct consequence?[J].Musculoskelet Surg,2014,98(1):9-14.
[17] WILKINSON D J,PIASECKI M,ATHERTON P J.The age-related loss of skeletal muscle mass and function:measurement and physiology of muscle fibre atrophy and muscle fibre loss in humans[J].Ageing Res Rev,2018,47:123-132.
[18] CHUA S K K,LIM C J,PUA Y H,et al.Is kinesiophobia associated with quality of life,level of physical activity,and function in older adults with knee osteoarthritis?[J/OL].Clin Orthop Relat Res,2024[2025-01-03].https://pubmed.ncbi.nlm.nih.gov/39387500/.
[19] WU Q M,XU Z Y,HUANG W H,et al.Effect of high plant protein/peptide nutrition supplementation on knee osteoarthritis in older adults with sarcopenia:a randomized,double-blind,placebo-controlled trial[J].Clin Nutr,2024,43(9):2177-2185.
[20] TAN B,YAN Y,ZHOU Q J,et al.Kinesitherapy for knee osteoarthritis patients physical and psychological health based on “Traditional Chinese Exercise”management modalities:a systematic review and meta-analysis of randomized controlled trials[J].Orthop Surg,2024,16(1):3-16.

相似文獻/References:

[1]樊慶陽,任凱晶.定制3D打印切模輔助全膝關(guān)節(jié)置換術(shù)治療 膝骨關(guān)節(jié)炎合并股骨干骨折畸形愈合[J].中醫(yī)正骨,2015,27(11):37.
[2]劉曉雅,孫永強,劉國杰.主動快速康復(fù)鍛煉對全膝關(guān)節(jié)置換術(shù)后關(guān)節(jié)活動度的影響[J].中醫(yī)正骨,2015,27(09):73.
[3]鄭春松,葉蕻芝,李西海,等.透骨消痛膠囊中補腎柔肝藥和活血祛風(fēng)藥治療 骨關(guān)節(jié)炎作用方式的計算機模擬比較[J].中醫(yī)正骨,2015,27(07):6.
 ZHENG Chunsong,YE Hongzhi,LI Xihai,et al.Comparison of the mode of action of Bushen Rougan(補腎柔肝)drugs versus Huoxue Qufeng(活血祛風(fēng))drugs contained in Tougu Xiaotong Jiaonang(透骨消痛膠囊)for the treatment of osteoarthritis:A computer simulation study[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(03):6.
[4]宋兵華,孫俊英,倪增良,等.全膝關(guān)節(jié)置換術(shù)前CT測量股骨后髁角的臨床意義[J].中醫(yī)正骨,2015,27(07):38.
[5]鄭春松,葉蕻芝,李西海,等.獨活寄生湯含藥血清對白細胞介素1β誘導(dǎo)的 退變關(guān)節(jié)軟骨細胞中基質(zhì)金屬蛋白酶 和環(huán)氧化酶2表達的影響[J].中醫(yī)正骨,2015,27(12):1.
 ZHENG Chunsong,YE Hongzhi,LI Xihai,et al.Impact of Duhuo Jisheng Tang(獨活寄生湯)medicated serum on expression of matrix metalloproteinase and cyclooxygenase 2 in degenerative articular chondrocytes induced by interleukin-1 beta[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(03):1.
[6]王金良,孫京濤,李玲,等.骨水泥聯(lián)合螺釘修復(fù)全膝關(guān)節(jié)置換術(shù)中 脛骨平臺內(nèi)側(cè)骨缺損[J].中醫(yī)正骨,2015,27(12):55.
[7]馮榮,王平,李炳奇,等.鈹針刺絡(luò)拔罐結(jié)合中藥口服治療膝骨關(guān)節(jié)炎合并 原發(fā)性血小板增多癥1例[J].中醫(yī)正骨,2015,27(12):73.
[8]蔡云仙.圍手術(shù)期耳穴按壓聯(lián)合平衡針療法 在全膝關(guān)節(jié)置換術(shù)后鎮(zhèn)痛中的應(yīng)用[J].中醫(yī)正骨,2015,27(06):41.
[9]張榮,王健.人工全膝關(guān)節(jié)置換術(shù)的圍手術(shù)期心理護理[J].中醫(yī)正骨,2015,27(05):77.
[10]喻長純,楊明路,王戰(zhàn)朝.不同手術(shù)方式治療脛骨平臺骨折畸形愈合的體會[J].中醫(yī)正骨,2015,27(03):37.
[11]孟維娜,明立功,王新德,等.關(guān)節(jié)鏡下清理聯(lián)合腓骨近1/3段截骨治療膝骨關(guān)節(jié)炎[J].中醫(yī)正骨,2015,27(11):40.
[12]明立功,孟維娜,王新德,等.腓骨近端截骨治療內(nèi)側(cè)間室膝骨關(guān)節(jié)炎的近期療效觀察[J].中醫(yī)正骨,2015,27(10):25.
[13]張杰,王人彥,張玉柱.膝骨關(guān)節(jié)炎的治療進展[J].中醫(yī)正骨,2015,27(10):68.
[14]梁朝,蔡靜怡,閆立,等.針刀療法改善膝骨關(guān)節(jié)炎早期疼痛癥狀的療效評價[J].中醫(yī)正骨,2015,27(09):9.
 LIANG Zhao,CAI Jingyi,YAN Li,et al.Evaluation of the curative effect of needle-knife therapy for relieving knee pain in patients with early knee osteoarthritis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(03):9.
[15]王建武,黨建軍,李強,等.四聯(lián)療法治療膝骨關(guān)節(jié)炎[J].中醫(yī)正骨,2015,27(08):44.
[16]劉紅娟,郭會利,郭樹農(nóng).云克聯(lián)合中藥治療膝骨關(guān)節(jié)炎的護理[J].中醫(yī)正骨,2015,27(08):75.
[17]陳衛(wèi)衡.探索建立系統(tǒng)的膝骨關(guān)節(jié)炎中醫(yī)臨床科研范式 和理論體系[J].中醫(yī)正骨,2015,27(07):1.
[18]帥波,沈霖,楊艷萍,等.加味青娥丸治療膝骨關(guān)節(jié)炎的作用機制研究[J].中醫(yī)正骨,2015,27(07):15.
 SHUAI Bo,SHEN Lin,YANG Yanping,et al.Study on the mechanism of action of Jiawei Qing'e Wan(加味青娥丸)for the treatment of knee osteoarthritis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(03):15.
[19]梅其杰,袁長深,段戡,等.壯藥骨痹方燙熨聯(lián)合運動療法治療膝骨關(guān)節(jié)炎的臨床研究[J].中醫(yī)正骨,2015,27(07):27.
 MEI Qijie,YUAN Changshen,DUAN Kan,et al.Clinical study of the curative effect of hot compressing and rubbing with packet of Gubi Fang(骨痹方)combined with exercise therapy in the treatment of knee osteoarthritis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(03):27.
[20]王丹輝,張燕,劉麗娟,等.重組人Ⅱ型腫瘤壞死因子受體-抗體融合蛋白 關(guān)節(jié)腔注射聯(lián)合中藥薰洗治療膝骨關(guān)節(jié)炎的臨床研究[J].中醫(yī)正骨,2015,27(07):31.
 WANG Danhui,ZHANG Yan,LIU Lijuan,et al.Clinical study on intra-articular injection of TypeⅡrecombinant human tumor necrosis factor receptor-Fc fusion protein combined with Chinese herbal steaming and washing therapy for treatment of knee osteoarthritis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(03):31.

備注/Memo

備注/Memo:
基金項目:四川省衛(wèi)生和健康委員會科研課題(21PJ011)
通訊作者:陳敏 E-mail:[email protected]
更新日期/Last Update: 1900-01-01